US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Johnson & Johnson (NY:JNJ)

256.03 -2.63 (-1.02%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The Investing Playbook for Retirees Who Can't Afford to Lose ↗
It may not be possible to avoid all risks, but it's certainly possible to minimize them. 
Via The Motley Fool
Topics Economy Retirement
News headline image
Meet the Vanguard ETF That Increased Its SpaceX Holding by 39% in 1 Month and Shows No Signs of Slowing Down ↗
The unlocking of SpaceX shares is reshaping the communications sector. 
Via The Motley Fool
Topics ETFs
Johnson & Johnson (NYSE:JNJ): A Dividend Quality Pick for Income Investors ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
Which dow jones stocks are moving on Friday? ↗
Via Chartmill
News headline image
Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue? ↗
One healthcare dividend payer carries legal risk, the other faces a buyout. Here's which one actually deserves your money. 
Via The Motley Fool
News headline image
Johnson & Johnson Sees Path to Double-Digit Growth Despite 2026 Patent Cliff ↗
Johnson & Johnson (NYSE:JNJ) Executive Vice President and Chief Financial Officer Joe Wolk said the company sees a path to growth above its previously stated 5% to 7% long-term range, supported by its... 
Via MarketBeat
Topics Intellectual Property
News headline image
The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks ↗
As Fed and inflation worries mount, Casey's General Stores, Johnson & Johnson, and PepsiCo stand out as defensive dividend payers with healthy balance sheets, growing payouts, and buyback programs. 
Via MarketBeat
Topics Economy
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
Is AbbVie the Best Dividend King to Buy in September? ↗
It is certainly a good Dividend King to buy in September. 
Via The Motley Fool
Topics Intellectual Property
News headline image
My Top 5 Favorite Stocks for an Uncertain Market ↗
These players offer a certain level of stability in any market environment. 
Via The Motley Fool
Topics Artificial Intelligence Economy Intellectual Property
Discover which dow jones stocks are making waves on Tuesday. ↗
Via Chartmill
News headline image
3 Healthcare Stocks for 3 Stages of Life ↗
Healthcare stocks Eli Lilly, UnitedHealth Group, and Johnson & Johnson offer options for investors of different ages, combining growth potential, turnaround momentum, and reliable dividends. 
Via MarketBeat
News headline image
Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition ↗
Johnson & Johnson (NYSE:JNJ) executives said the company remains on track to grow through biosimilar competition for STELARA and expects its portfolio of medicines, medical devices and pipeline... 
Via MarketBeat
Topics ETFs Economy
News headline image
2 Outstanding Dividend Stocks to Buy and Hold for 10 Years ↗
Income seekers can't go wrong with these companies. 
Via The Motley Fool
Topics Intellectual Property
Friday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
News headline image
These 5 ETFs Are Built for Bear Markets. History Says Now Is a Fantastic Time to Buy. ↗
During bear markets and recessions, it's good to be invested in "defensive" stocks and funds that hold up better than average. 
Via The Motley Fool
Topics ETFs Economy
Which dow jones stocks are moving on Thursday? ↗
Via Chartmill
News headline image
Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center Stage ↗
Johnson & Johnson (NYSE:JNJ) MedTech Chairman Tim Schmid said the company remains confident it is delivering growth at the high end of its previously stated 5% to 7% operational market-growth range for... 
Via MarketBeat
Topics ETFs Economy
Stay informed with the top movers within the dow jones index on Wednesday. ↗
Via Chartmill
News headline image
2 Dividend Stocks Built to Hold Up When Markets Don't ↗
These two are on the Dividend Kings list. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
If I Were in My 20s, I'd Buy This Vanguard ETF Warren Buffett Recommended and Hold It Forever ↗
Low-cost index funds can be a ticket to prosperity for everyday investors. 
Via The Motley Fool
Topics ETFs Economy
Stay informed with the top movers within the dow jones index on Tuesday. ↗
Via Chartmill
What's going on in today's session: dow jones movers ↗
Via Chartmill
News headline image
5 Defensive Stocks to Watch as CPI and the Fed Put the Rally to the Test ↗
Ahead of CPI data and the Fed's rate decision, defensive stocks McDonald's, Johnson & Johnson, Walmart, Berkshire Hathaway, and NextEra Energy offer stability and dividends amid market uncertainty. 
Via MarketBeat
Topics Economy
News headline image
If the Fed Hikes Interest Rates This Month, History Says This Is the Smartest ETF to Buy Right Now ↗
If interest rates rise, writing a prescription today for the State Street Health Care Select Sector SPDR ETF is a smart idea. 
Via The Motley Fool
Topics ETFs Economy Regulatory Compliance
News headline image
Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning? ↗
Intuitive Surgical's flywheel isn't selling new surgical robots, its selling parts and services to support the ones it has already sold. 
Via The Motley Fool
News headline image
Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
From Johnson & Johnson
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >